Leuplinforection and aspartate aminotransferase increased Patient Reports February 11, 2012

Leuplinforection Side Effects Report #5214768-8
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hot flush, malignant neoplasm progression, prostate cancer stage iv. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.

Leuplinforection Side Effects Report #5197711-X
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2006. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hepatic function abnormal, hot flush, malignant neoplasm progression. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK), SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.

Leuplinforection Side Effects Report #6133968-6
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2009. Male patient, 62 years of age, was diagnosed with prostate cancer stage iv, cancer pain, prophylaxis, ulcer  and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, prostate cancer . Leuplinforection dosage: unknown. During the same period patient was treated with CASODEX, DECADRON, OXYCONTIN, GASTER, LOXONIN. Patient died on 02/14/2008.

Leuplinforection Side Effects Report #6135869-6
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2009. Male patient, 62 years of age, was diagnosed with prostate cancer stage iv, cancer pain, prophylaxis against gastrointestinal ulcer and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, prostate cancer . Leuplinforection dosage: unknown. During the same period patient was treated with CASODEX, DECADRON, OXYCONTIN, GASTER, LOXONIN. Patient died on 02/14/2008.